PRFX News and Press, PainReform Ltd. From 04/17/23

TEL AVIV, Israel, April 17, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer...

TEL AVIV, Israel, March 28, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced completion of treatment for the first part, of...

TEL AVIV, Israel, March 16, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the year ended December 31, 202...

TEL AVIV, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it has commenced a Phase 3 clinical trial...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com Lixte Biotech (NASDAQ: LIXT ) stock is dropping on Wednesday but it’s not due to any negative news from the drug discovery company. Instead, it’s the result of sh...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: OlegRi / Shutterstock.com SINTX Technologies (NASDAQ: SINT ) stock is falling on Wednesday after the company priced a public stock offering . That public stock offering has the company selling 2.15 millio...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Peshkova Aurora Mobile (NASDAQ: JG ) stock is on the rise Wednesday after the company announced its plans to add AI to its services . A press release from the company reveals it intends t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock PainReform (NASDAQ: PRFX ) stock is rocketing higher on Wednesday following an update on its delisting ordeal . A press release confirms that the company has received a letter from The Nasda...

PainReform ( NASDAQ: PRFX ) said it had received a letter from the Nasdaq stating it was eligible for an additional 180 day period, or until August 7, to regain compliance with the minimum $1 bid price per share requirement. For further details see: PainReform receives Nasda...

TEL AVIV, Israel, Feb. 07, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, announced today that on February 7, 2023, it rec...